Researchers develop a new method for measuring and imaging how quickly blood flows in the brain.
Researchers discover why certain glioblastoma brain tumors are resistant to drugs.
Researchers report the antidepressant drug Rolipram could be used to effectively treat medulloblastoma brain cancer.
Researchers have discovered a way to diagnose brain cancer based on genetic markers found in junk DNA.
Targeting aPKC, a protein crucial for neurodevelopment, researchers report they can block multiple signaling pathways implicated in brain tumor growth.
Researchers report gliomas do not grow their own blood vessels.
Researchers discover glioblastoma brain tumor cells disrupt the blood brain barrier. The findings offer potential new avenues to treat brain cancer.
Researchers show SUMO family proteins are key to why glioblastoma tumors multiply uncontrollably.
Researchers have discovered a biomarker which predicts whether glioblastoma brain tumors will respond to chemotherapy.
Researchers shed new light on how glioma cells migrate in the brain and cause tumors.
Researchers have identified two oncogenes that drive the development of medulloblastoma brain cancer.
Researchers find high levels of progesterone can kill glioblastoma cells and inhibit brain tumor growth.
Researchers reveal the cellular makeup of each glioblastoma brain tumor is more heterogeneous than previously believed.
New research reveals two common gene variants which lead to longer telomeres also significantly increase the risk of developing gliomas.
Researchers identify a possible, common source of DNA damage which could play a role in neurodegenerative diseases, cancer and aging.